These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9596087)
21. Out-of-pocket costs and productivity losses in haemodialysis and peritoneal dialysis from a patient interview survey in Taiwan. Tang CH; Chen HH; Wu MJ; Hsu BG; Tsai JC; Kuo CC; Lin SP; Chen TH; Sue YM BMJ Open; 2019 Mar; 9(3):e023062. PubMed ID: 30904836 [TBL] [Abstract][Full Text] [Related]
22. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis. Wong CKH; Chen J; Fung SKS; Mok MMY; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK Nephrol Dial Transplant; 2019 Sep; 34(9):1565-1576. PubMed ID: 30668781 [TBL] [Abstract][Full Text] [Related]
23. Cost analysis of renal replacement therapy by transplant in a system of bundled payment of dialysis. Rocha MJ; Ferreira S; Martins LS; Almeida M; Dias L; Pedroso S; Henriques AC; Almeida R; Cabrita A Clin Transplant; 2012; 26(4):529-31. PubMed ID: 22211715 [TBL] [Abstract][Full Text] [Related]
24. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients. Shih YC; Guo A; Just PM; Mujais S Kidney Int; 2005 Jul; 68(1):319-29. PubMed ID: 15954923 [TBL] [Abstract][Full Text] [Related]
25. Service Utilization Patterns and Direct Medical Costs of Hospitalization in Patients With Renal Failure Before and After Initiating Home Peritoneal Dialysis. Torres-Toledano M; Granados-García V; Cortés-Sanabria L; Cueto-Manzano AM; Flores YN; Salmerón J Value Health Reg Issues; 2024 May; 41():114-122. PubMed ID: 38325244 [TBL] [Abstract][Full Text] [Related]
26. The cost of renal dialysis in a UK setting--a multicentre study. Baboolal K; McEwan P; Sondhi S; Spiewanowski P; Wechowski J; Wilson K Nephrol Dial Transplant; 2008 Jun; 23(6):1982-9. PubMed ID: 18174268 [TBL] [Abstract][Full Text] [Related]
28. Exploring kidney dialysis costs in the United States: a scoping review. Stewart F; Kistler K; Du Y; Singh RR; Dean BB; Kong SX J Med Econ; 2024; 27(1):618-625. PubMed ID: 38605648 [TBL] [Abstract][Full Text] [Related]
29. Comparison of Patient Survival Between Hemodialysis and Peritoneal Dialysis Among Patients Eligible for Both Modalities. Wong B; Ravani P; Oliver MJ; Holroyd-Leduc J; Venturato L; Garg AX; Quinn RR Am J Kidney Dis; 2018 Mar; 71(3):344-351. PubMed ID: 29174322 [TBL] [Abstract][Full Text] [Related]
30. Financial implications of dialysis modalities in the developing world: A Chinese perspective. Liu J; Hutton DW; Gu Y; Hu Y; Li Y; Ma L; Zeng X; Fu P Perit Dial Int; 2020 Mar; 40(2):193-201. PubMed ID: 32063196 [TBL] [Abstract][Full Text] [Related]
31. Health economic evaluations: the special case of end-stage renal disease treatment. Winkelmayer WC; Weinstein MC; Mittleman MA; Glynn RJ; Pliskin JS Med Decis Making; 2002; 22(5):417-30. PubMed ID: 12365484 [TBL] [Abstract][Full Text] [Related]
32. Hospital Utilization and Costs in Older Patients with Advanced Chronic Kidney Disease Choosing Conservative Care or Dialysis: A Retrospective Cohort Study. Verberne WR; Ocak G; van Gils-Verrij LA; van Delden JJM; Bos WJW Blood Purif; 2020; 49(4):479-489. PubMed ID: 31927544 [TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of hemodialysis and peritoneal dialysis: A national cohort study with 14 years follow-up and matched for comorbidities and propensity score. Chang YT; Hwang JS; Hung SY; Tsai MS; Wu JL; Sung JM; Wang JD Sci Rep; 2016 Jul; 6():30266. PubMed ID: 27461186 [TBL] [Abstract][Full Text] [Related]
34. Financial implications of choice of dialysis type of the revised Medicare payment system: an economic analysis. Hornberger J; Hirth RA Am J Kidney Dis; 2012 Aug; 60(2):280-7. PubMed ID: 22560829 [TBL] [Abstract][Full Text] [Related]
35. Economic impact of extended time on peritoneal dialysis as a result of using polyglucose: the application of a Markov chain model to forecast changes in the development of the ESRD programme over time. Weijnen TJ; van Hamersvelt HW; Just PM; Struijk DG; Tjandra YI; ter Wee PM; de Charro FT Nephrol Dial Transplant; 2003 Feb; 18(2):390-6. PubMed ID: 12543897 [TBL] [Abstract][Full Text] [Related]
36. The financial implications for Medicare of greater use of peritoneal dialysis. Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160 [TBL] [Abstract][Full Text] [Related]
37. Economic evaluation of dialysis therapies. Klarenbach S; Manns B Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898 [TBL] [Abstract][Full Text] [Related]
38. End-stage renal disease-financial costs and years of life lost in Panama: a cost-analysis study. Moreno Velásquez I; Tribaldos Causadias M; Valdés R; Gómez B; Motta J; Cuero C; Herrera-Ballesteros V BMJ Open; 2019 May; 9(5):e027229. PubMed ID: 31133590 [TBL] [Abstract][Full Text] [Related]
39. Hospital resource utilization that occurs with, rather than because of, kidney failure in patients with end-stage renal disease. Ross EA; Alza RE; Jadeja NN Clin J Am Soc Nephrol; 2006 Nov; 1(6):1234-40. PubMed ID: 17699353 [TBL] [Abstract][Full Text] [Related]
40. Understanding cost of care for patients on renal replacement therapy: looking beyond fixed tariffs. Li B; Cairns JA; Fotheringham J; Tomson CR; Forsythe JL; Watson C; Metcalfe W; Fogarty DG; Draper H; Oniscu GC; Dudley C; Johnson RJ; Roderick P; Leydon G; Bradley JA; Ravanan R Nephrol Dial Transplant; 2015 Oct; 30(10):1726-34. PubMed ID: 26071229 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]